國立虎尾科技大學 |

Systems Biomedicine Approaches in Cancer Research

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Systems Biomedicine Approaches in Cancer Research/ edited by Shailza Singh.
其他作者:	Singh, Shailza.
面頁冊數:	XI, 163 p. 1 illus.online resource. :
Contained By:	Springer Nature eBook
標題:	Cancer Therapy. -
電子資源:	https://doi.org/10.1007/978-981-19-1953-4
ISBN:	9789811919534

Systems Biomedicine Approaches in Cancer Research
Systems Biomedicine Approaches in Cancer Research[electronic resource] /edited by Shailza Singh. - 1st ed. 2022. - XI, 163 p. 1 illus.online resource.

Chapter 1_Systems Complexity in Cancer -- Chapter 2_Engineered Biotherapeutics through Synthetic Biology in Cancer -- Chapter 3_Cancer Immunotherapy: A Potential Convergence between Systems and Synthetic Biology -- Chapter 4_Cell Based Therapeutic Devices in Cancer -- Chapter 5_Case Studies on Medicinal Plants in Cancer Drug Discovery using System Approaches -- Chapter 7_Metabolic engineering and synthetic biology devices in treating Cancer -- Chapter 8_Cancer Biomarkers in the era of Systems Biology -- Chapter 9_Supervised vs Non-Supervised Learning to Combat Cancer -- Chapter 10_Designing Cancer Biological Systems using Synthetic Engineering -- Chapter 11_Biosystems and Genetic Engineering Tools in Cancer Theranostics -- Chapter 12_Role of HPC in Cancer Informatics -- Chapter 13_Statistical ML for Cancer Therapeutics -- Chapter 14_Data Mining and Knowledge Discovery in Cancer -- Chapter 15_TCGA Data from TensorFlow Optimization.

This book presents the applications of systems biology and synthetic biology in cancer medicine. It highlights the use of computational and mathematical models to decipher the complexity of cancer heterogeneity. The book emphasizes the modeling approaches for predicting behavior of cancer cells, tissues in context of drug response, and angiogenesis. It introduces cell-based therapies for the treatment of various cancers and reviews the role of neural networks for drug response prediction. Further, it examines the system biology approaches for the identification of medicinal plants in cancer drug discovery. It explores the opportunities for metabolic engineering in the realm of cancer research towards development of new cancer therapies based on metabolically derived targets. Lastly, it discusses the applications of data mining techniques in cancer research. This book is an excellent guide for oncologists and researchers who are involved in the latest cancer research.

ISBN: 9789811919534

Standard No.: 10.1007/978-981-19-1953-4doiSubjects--Topical Terms:

1389305
Cancer Therapy.

LC Class. No.: QH324

Dewey Class. No.: 570.724

Systems Biomedicine Approaches in Cancer Research
LDR:03263nam a22003975i 4500 001 1089591
003 DE-He213
005 20220810151245.0
007 cr nn 008mamaa
008 221228s2022 si | s |||| 0|eng d
020 $a 9789811919534 $9 978-981-19-1953-4
024 7 $a 10.1007/978-981-19-1953-4 $2 doi
035 $a 978-981-19-1953-4
050 4 $a QH324
072 7 $a PSB $2 bicssc
072 7 $a SCI010000 $2 bisacsh
072 7 $a PSE $2 thema
082 0 4 $a 570.724 $2 23
245 1 0 $a Systems Biomedicine Approaches in Cancer Research $h [electronic resource] / $c edited by Shailza Singh.
250 $a 1st ed. 2022.
264 1 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a XI, 163 p. 1 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1_Systems Complexity in Cancer -- Chapter 2_Engineered Biotherapeutics through Synthetic Biology in Cancer -- Chapter 3_Cancer Immunotherapy: A Potential Convergence between Systems and Synthetic Biology -- Chapter 4_Cell Based Therapeutic Devices in Cancer -- Chapter 5_Case Studies on Medicinal Plants in Cancer Drug Discovery using System Approaches -- Chapter 7_Metabolic engineering and synthetic biology devices in treating Cancer -- Chapter 8_Cancer Biomarkers in the era of Systems Biology -- Chapter 9_Supervised vs Non-Supervised Learning to Combat Cancer -- Chapter 10_Designing Cancer Biological Systems using Synthetic Engineering -- Chapter 11_Biosystems and Genetic Engineering Tools in Cancer Theranostics -- Chapter 12_Role of HPC in Cancer Informatics -- Chapter 13_Statistical ML for Cancer Therapeutics -- Chapter 14_Data Mining and Knowledge Discovery in Cancer -- Chapter 15_TCGA Data from TensorFlow Optimization.
520 $a This book presents the applications of systems biology and synthetic biology in cancer medicine. It highlights the use of computational and mathematical models to decipher the complexity of cancer heterogeneity. The book emphasizes the modeling approaches for predicting behavior of cancer cells, tissues in context of drug response, and angiogenesis. It introduces cell-based therapies for the treatment of various cancers and reviews the role of neural networks for drug response prediction. Further, it examines the system biology approaches for the identification of medicinal plants in cancer drug discovery. It explores the opportunities for metabolic engineering in the realm of cancer research towards development of new cancer therapies based on metabolically derived targets. Lastly, it discusses the applications of data mining techniques in cancer research. This book is an excellent guide for oncologists and researchers who are involved in the latest cancer research.
650 2 4 $a Cancer Therapy. $3 1389305
650 2 4 $a Computational and Systems Biology. $3 1365723
650 2 4 $a Cancer Biology. $3 1388882
650 0 $a Cancer—Treatment. $3 1389304
650 0 $a Bioinformatics. $3 583857
650 0 $a Cancer. $3 581034
650 0 $a Synthetic Biology. $3 1004144
700 1 $a Singh, Shailza. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1113336
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811919527
776 0 8 $i Printed edition: $z 9789811919541
776 0 8 $i Printed edition: $z 9789811919558
856 4 0 $u https://doi.org/10.1007/978-981-19-1953-4
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)